Mrs. Vivian Jannette Joglar, RN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: Bo Machuelo Carretera 14, Hospital Stq Forense Ponce, Ponce, PR 00731 Phone: 787-844-0101 |
Mr. Luis Doel Laboy, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: Ave. Tito Castro, Barrio Machuelo, Ponce, PR 00732 Phone: 787-844-0101 |
Ms. Carmen M Rivera-torres, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: Paseo Del Veterano 1010, Va Ponce Outpatient Clinic, Ponce, PR 00716 Phone: 787-812-3030 Fax: 787-651-4321 |
Javier Quintana Padilla, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: Ponce Ave Tito Castro Al Lados De San Lucus, Hospital Siquiatria Forence #2, Ponce, PR 00731 Phone: 787-487-5226 |
Sonia Santiago, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: Carr 14 Ave Tito Castro, Ponce, PR 00732 Phone: 787-840-6630 Fax: 787-844-4130 |
Yasmin Santiago, RN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: Hospital Inspira Behavioral, Calle Guadalupe 184, Ponce, PR 00730 Phone: 787-704-0705 |
Eligia Santiago, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: Tito Castro Ave, Box 7321, Ponce, PR 00732 Phone: 787-844-0101 |
News Archive
Introducing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut health care spending in the United States by $54 billion over the next decade, according to new analysis from the RAND Corporation.
The proposed 2.3 percent reduction in (Medicare Advantage plan) payments, which comes on top of cuts already scheduled under the Affordable Care Act, pays no mind to the potential impact on quality of care throughout the program. These cuts will apply to all plans no matter the value they bring in providing quality care to beneficiaries or offering innovative solutions that could ultimately be scaled and applied to the broader program.
Abbott today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in symptoms.
InterMune, Inc. today announced results from operations for the second quarter and six months ended June 30, 2010. InterMune also highlighted its recent clinical development and business activities, and provided forward-looking financial guidance for 2010.
› Verified 8 days ago